Drug Type Fusion protein |
Synonyms- |
Target |
Action modulators |
Mechanism FGF21 modulators(Fibroblast growth factor 21 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | China | 18 Sep 2022 | |
Nonalcoholic Steatohepatitis | Preclinical | China | 18 Sep 2022 | |
Obesity | Preclinical | China | 18 Sep 2022 |